Raloxifene: what it treats, how to take it, side effects
Last updated September 3, 2026.
Raloxifene is a selective estrogen receptor modulator - it mimics estrogen's bone-protecting effects while blocking estrogen's effects on breast tissue. You may know it as Evista. One daily tablet, two protections - and one boxed warning about blood clots that shapes how you live on it.
What does it treat?
Two jobs in postmenopausal women: preventing and treating osteoporosis, and decreasing the risk of invasive breast cancer in women at high risk or with osteoporosis. The boundaries are explicit: it cannot treat invasive breast cancer, cannot prevent its return in women who have had it, cannot lower the risk of noninvasive breast cancer, and is not for women before menopause.
How do you take it?
One tablet once a day, with or without food, same time daily, continued even when you feel well. The clot warning writes the lifestyle rules: stop it at least 3 days before scheduled surgery and during any extended bed rest; on long trips, avoid sitting still for long stretches - walk the aisle, move your calves. Missed dose: take it when you remember unless the next one is close; never double up.
Side effects to know
- Common: hot flashes (worst in the first 6 months), leg cramps, swelling of the hands, feet, ankles, or lower legs, flu-like feelings, joint pain, sweating, and sleep trouble.
- Serious - stop taking it and call your doctor immediately: the clot pattern - leg pain, warmth in the lower leg, swelling of the hands, feet, ankles, or lower legs, sudden chest pain, shortness of breath, coughing up blood, or sudden vision changes including loss of vision or blurred vision.
Who should not take it?
Anyone who has ever had a blood clot in the legs, lungs, or eyes - the label says your doctor will probably not prescribe it. Coronary artery disease or high risk for it shifts the balance: raloxifene may raise the chance of a serious or fatal stroke there, so stroke or mini-stroke history, smoking, high blood pressure, and irregular heartbeat all belong in the decision. Not for premenopausal women. If you become pregnant, call your doctor.
When is it an emergency?
Sudden chest pain, coughing blood, shortness of breath, a hot swollen calf, or sudden vision loss is a 911 call. For an overdose, call Poison Control at 1-800-222-1222. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Why does a bone drug come with a blood-clot warning?
The estrogen mimicry cuts both ways - the same pathway that protects bone also shifts clotting, and the boxed warning is direct: increased risk of clots in the legs or lungs. A past clot usually rules the drug out. The symptom set is specific: leg pain or warmth, swelling, sudden chest pain, shortness of breath, coughing blood, sudden vision changes. Any of them means stop and call immediately.
Why do I have to stop raloxifene before surgery?
Stillness plus a clot-shifting drug is the dangerous combination - the warning says to stop at least 3 days before scheduled surgery and to avoid it during extended bed rest. Same logic on long flights and car trips: keep moving, flex the calves, walk the aisle. Tell every surgeon and dentist you take it; the pause is routine, not an emergency.
Why is raloxifene not for women before menopause?
Its benefit-risk math was established in postmenopausal women, and MedlinePlus states it should not be used before menopause - the estrogen environment is different and the protections do not transfer. Premenopausal bone loss and breast-cancer risk reduction are different conversations with different tools.
How can one drug protect bones but block breast cancer?
That is what "selective" means: raloxifene activates estrogen receptors in bone - building density - while blocking them in breast tissue, where estrogen feeds certain tumors. Two effects, one molecule. The limits are equally specific: it lowers the risk of invasive breast cancer; it does not treat it, does not prevent recurrence, and does not touch noninvasive disease.
Why did my doctor ask about my heart before prescribing?
The stroke clause: with coronary artery disease or high risk for it, raloxifene may raise the chance of a serious or fatal stroke. So the history - prior stroke or mini-stroke, smoking, blood pressure, heart rhythm - is part of the weighing, not paperwork. For many women the bone and breast benefits win clearly; for some cardiac profiles they do not.
What happens if I miss a dose of raloxifene?
Take it as soon as you remember, unless it is almost time for the next one - then skip it and never double up. Bone protection accumulates over months and years; a single missed tablet costs nothing measurable. Same-time-daily anchoring keeps the pattern steady.